RAVEN BIOTECHNOLOGIES
Raven biotechnologies, Inc., a biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer. Its lead product candidate, RAV12, targets adenocarcinomas and used for the treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is based in South San Francisco, California. As of July 17, 2008, Raven Biotechnologies, Inc. operates as a subsidiary of MacroGenics, Inc.
RAVEN BIOTECHNOLOGIES
Industry:
Biotechnology Medical Therapeutics
Founded:
1999-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.macrogenics.com
Total Employee:
51+
Status:
Active
Total Funding:
88.3 M USD
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Amivas
Amivas is an Australian, Canadian and US joint venture that focuses on the development of therapeutics for the treatment of diseases.
Boston Biomedical
Boston Biomedical focuses on the research and development of novel therapeutics to treat cancer.
Planet Biotechnology
Planet Biotechnology is a clinical-stage company that develops monoclonal antibody-based therapeutic and preventative products.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Staten Biotechnology
Staten Biotechnology is a developer of a human monoclonal antibody intended to treat dyslipidemia.
Xori Corporation
XORI Corporation develops technology for discovery and development of monoclonal antibodies which are used to treat cancers, immune
Current Advisors List
Founder
Investors List
Biogen Idec
Biogen Idec investment in Series D - Raven Biotechnologies
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Series D - Raven Biotechnologies
Hambrecht & Quist Capital Management
Hambrecht & Quist Capital Management investment in Series D - Raven Biotechnologies
CIDC Consultants
CIDC Consultants investment in Series D - Raven Biotechnologies
Milepost Ventures
Milepost Ventures investment in Series D - Raven Biotechnologies
CMEA Capital
CMEA Capital investment in Series D - Raven Biotechnologies
Bear Stearns
Bear Stearns investment in Series D - Raven Biotechnologies
Integra Ventures
Integra Ventures investment in Series D - Raven Biotechnologies
Vulcan Capital
Vulcan Capital investment in Series D - Raven Biotechnologies
U.S. Venture Partners
U.S. Venture Partners investment in Series D - Raven Biotechnologies
Official Site Inspections
http://www.macrogenics.com
- Host name: 77.113.185.35.bc.googleusercontent.com
- IP address: 35.185.113.77
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
